NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 11.80% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.96% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 6.37% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.96% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 5.68% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.62% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.56% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.51% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.13% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.00% |
| 7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 3.59% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.31% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.04% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 2.97% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.95% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.69% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.41% |
| 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 2.27% |